Skip to main content
KMPHARMACEUTICAL Co.,Ltd. logo

KMPHARMACEUTICAL Co.,Ltd. — Investor Relations & Filings

Ticker · 225430 ISIN · KR7225430008 KO Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2021-07-16 M&A Activity
Country KR South Korea
Listing KO 225430

About KMPHARMACEUTICAL Co.,Ltd.

https://en.kmkmp.com/

KMPHARMACEUTICAL Co., Ltd. is a company that develops, manufactures, and distributes personal care products. Its core business areas include oral care solutions, such as toothpaste and toothbrushes; beauty and skincare products; and a dedicated line of items for infants and children. The company leverages its research and development expertise to provide Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, creating customized products tailored to client needs in the oral care and cosmetics sectors. It focuses on developing innovative solutions and adheres to strict quality standards, particularly for its children's product lines.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유형자산양수결정)
M&A Activity Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previous 'Major Matter Report' (주요사항보고서) concerning the acquisition of tangible assets (유형자산 양수 결정). It details changes to the acquisition amount, payment schedule, and external evaluation status. In the context of Korean regulatory filings (DART), this is a standard regulatory disclosure of a material corporate event. Since it does not fit into specific categories like M&A (which usually refers to corporate mergers/takeovers) or other specialized categories, it falls under the general regulatory filing category.
2021-07-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used when a major shareholder's stake or contract status changes. It details the shareholding of Kang Il-mo in KM Pharmaceutical Co., Ltd., specifically noting changes in collateralized loan agreements. This falls under the category of Major Shareholding Notification.
2021-07-13 Korean
[기재정정]주요사항보고서(유형자산양수결정)
M&A Activity Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previous 'Major Matter Report' (주요사항보고서) concerning the acquisition of tangible assets (유형자산 양수 결정). It details changes to the acquisition schedule and payment terms due to delays in equipment installation. In the context of Korean regulatory filings (DART), this is a formal regulatory disclosure of a material corporate event, which falls under the 'Regulatory Filings' category as it is a specific update to a previously filed material event report.
2021-06-30 Korean
[기재정정]주요사항보고서(유형자산양수결정)
M&A Activity Classification · 100% confidence The document is a 'Correction Report' (정정신고) filed by KM Pharmaceutical Co., Ltd. regarding a previous 'Major Report' (주요사항보고서) concerning the acquisition of tangible assets (machinery). It details specific changes to the acquisition date and payment schedule due to delays in trial operations. In the context of Korean regulatory filings (DART), this is a standard regulatory disclosure regarding material corporate events, which falls under the 'Regulatory Filings' category as it is a formal amendment to a previous disclosure.
2021-05-31 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) filed by KM Pharmaceutical Co., Ltd. (케이엠제약(주)) for the period of January 1, 2021, to March 31, 2021. It contains detailed financial and operational information, including company history, capital changes, and management details, which are characteristic of an interim/quarterly report. The document is a correction filing (정정신고) of the original quarterly report submitted on May 17, 2021. As it contains substantive financial and business data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2021
2021-05-31 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the period from January 1, 2021, to March 31, 2021, submitted to the Financial Services Commission and the Korea Exchange. It contains detailed corporate information, financial data, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.